Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Atara Biotherapeutics (ATRA) Return on Equity (2022 - 2026)

Atara Biotherapeutics filings provide 5 years of Return on Equity readings, the most recent being 0.01% for Q1 2026.

  • On a quarterly basis, Return on Equity rose 1.0% to 0.01% in Q1 2026 year-over-year; TTM through Mar 2026 was 0.01%, a 1.0% increase, with the full-year FY2025 number at 0.0%, up 88.0% from a year prior.
  • Return on Equity hit 0.01% in Q1 2026 for Atara Biotherapeutics, up from 0.0% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.13% in Q3 2023 to a low of 5.06% in Q1 2024.
  • Median Return on Equity over the past 5 years was 0.0% (2025), compared with a mean of 0.34%.
  • Biggest five-year swings in Return on Equity: crashed -503bps in 2024 and later skyrocketed 506bps in 2025.
  • Atara Biotherapeutics' Return on Equity stood at 0.01% in 2022, then crashed by -685bps to 0.11% in 2023, then soared by 108bps to 0.01% in 2024, then crashed by -100bps to 0.0% in 2025, then soared by 85260bps to 0.01% in 2026.
  • The last three reported values for Return on Equity were 0.01% (Q1 2026), 0.0% (Q4 2025), and 0.01% (Q3 2025) per Business Quant data.